Target intelligence / Profile preview

Taste receptor type 2 member 16 (TAS2R16)

Target
TAS2R16
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Taste receptor type 2 member 16 (TAS2R16) is a G protein-coupled receptor (GPCR) expressed in taste cells, primarily responsible for the detection of bitter β-glucoside compounds found in many plants and foods. Upon ligand binding, it activates a signal transduction pathway using gustducin and phospholipase C β2, ultimately leading to depolarization of taste cells and transmission of bitter taste signals to the brain. TAS2R16 has roles beyond oral taste perception, including functions in the gastrointestinal and respiratory tracts, and exhibits significant genetic diversity that influences individual taste preferences, dietary choices, and behavioral traits such as alcohol consumption and medication compliance. It interacts with a variety of natural and synthetic bitter compounds, with notable ligands like salicin and arbutin (which can function as agonist or inverse agonist depending on context). No FDA-approved drugs are known to target TAS2R16 for therapeutic use, but its activity and genetic variants are relevant as biomarkers for dietary selection and risk factors in certain behaviors and metabolic traits.

Other names
Taste receptor type 2 member TAS2R16TAS2R16Bitter taste receptor TAS2R16
02

Mechanism of action

Agonism (activation by β-glucoside ligands leads to signaling and bitter taste perception); Inverse agonism (arbutin, depending on species/context); Antagonism (some compounds inhibit receptor function).

03

Biological functions

Signal transductionBitter taste perceptionRegulation of dietary choicesPossible roles in innate immunity and respiratory functionRegulation of digestive function and metabolism
04

Disease associations

Other (influences dietary choices linked to health)Polymorphisms linked to alcohol dependence, body mass index, medication compliance
05

Safety considerations

No explicit safety concerns as a therapeutic target; modulation of this receptor can alter food perception and may affect compliance with oral medications, alcohol intake, and diet
06

Interacting drugs

Diphenidol

11 more in the full profile.

07

Biomarkers

Genetic polymorphisms (variants affecting sensitivity to bitter compounds, especially β-glucosides; e.g., amino acid 172 allelic variant linked to alcohol dependence and sensitivity differences)

Beyond the preview

Go deeper on Taste receptor type 2 member 16 (TAS2R16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taste receptor type 2 member 16 (TAS2R16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call